학술논문

A novel myelin P0–specific T cell receptor transgenic mouse develops a fulminant autoimmune peripheral neuropathy
Document Type
article
Source
Journal of Experimental Medicine. 206(3)
Subject
Neurosciences
Peripheral Neuropathy
Autoimmune Disease
Neurodegenerative
Brain Disorders
Aetiology
2.1 Biological and endogenous factors
Inflammatory and immune system
Neurological
Animals
Autoimmune Diseases
CD4-Positive T-Lymphocytes
Cell Proliferation
Cytokines
Epitopes
Hybridomas
Mice
Mice
Inbred NOD
Mice
Transgenic
Myelin P0 Protein
Peripheral Nerves
Peripheral Nervous System Diseases
Phenotype
Receptors
Antigen
T-Cell
alpha-beta
Medical and Health Sciences
Immunology
Language
Abstract
Autoimmune-prone nonobese diabetic mice deficient for B7-2 spontaneously develop an autoimmune peripheral neuropathy mediated by inflammatory CD4(+) T cells that is reminiscent of Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy. To determine the etiology of this disease, CD4(+) T cell hybridomas were generated from inflamed tissue-derived CD4(+) T cells. A majority of T cell hybridomas were specific for myelin protein 0 (P0), which was the principal target of autoantibody responses targeting nerve proteins. To determine whether P0-specific T cell responses were sufficient to mediate disease, we generated a novel myelin P0-specific T cell receptor transgenic (POT) mouse. POT T cells were not tolerized or deleted during thymic development and proliferated in response to P0 in vitro. Importantly, when bred onto a recombination activating gene knockout background, POT mice developed a fulminant form of peripheral neuropathy that affected all mice by weaning age and led to their premature death by 3-5 wk of age. This abrupt disease was associated with the production of interferon gamma by P0-specific T cells and a lack of CD4(+) Foxp3(+) regulatory T cells. Collectively, our data suggest that myelin P0 is a major autoantigen in autoimmune peripheral neuropathy.